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This report describes the elfects of two gram-negative bacterial endotoxin (lipopolysaccharide [LPS])
preparations on hamster pregnancy outcome variables. Single intravenous challenges with Escherichia coli and
Porphyromonas gingivalis LPS on day 8 of pregnancy produced dose-dependent effects on fetal weight
malformation and fetal resorption with E. coli LPS having potent embryolethal effects. Premating maternal
exposure to P. gingivalis produced embryolethal effects similar to those of E. coli. These data suggest that
maternal exposure to P. gingivalis LPS prior to and during pregnancy can induce deleterious effects on the
developing fetus.
To date the effects of endotoxins of oral origin on the
fetal-placental unit have not been examined. This is of poten-
tial significance since the molecular structure and biological
activities of endotoxins isolated from oral organisms are dif-
ferent from those of enteric endotoxins. Experiments were
conducted to compare the effects of enteric versus oral endo-
toxins on fetal development in the pregnant golden hamster
model. In addition, studies were performed to characterize
both the dose-response effects of lipopolysaccharide (LPS) on
pregnant dams and the effects of immunization prior to LPS
challenge on the pregnancy outcome.
Early experiments (1, 2, 5, 6) showed that enteric endotoxins
are capable of inducing placental necrosis, spontaneous abor-
tions, fetal organ damage, fetal death, and malformations in
various animal species. Endotoxin was found to be embryole-
thal and to produce several malformations, spontaneous abor-
tions, and low fetal weight. Administering Escherichia coli LPS
as a single intravenous bolus on day 8 of gestation, Lanning (4)
demonstrated a decrease in fetal weight and an increase in the
percentage of malformed fetuses with increasing LPS concen-
trations.
It is our hypothesis that the burden of oral endotoxin which
is associated with periodontal infection in humans may present
a risk for abnormal pregnancy outcomes. Although there are
considerable data indicating that systemic exposure to oral
LPS occurs, especially in the presence of periodontal infection,
the critical question remains as to whether oral endotoxins can
elicit adverse pregnancy outcomes. In this report, we demon-
strate that Porphyromonas gingivalis LPS can induce fetal
growth retardation, fetal death, resorptions, and malforma-
tions and that the dose-response characteristics differ signifi-
cantly from those of E. coli LPS. Furthermore, repeated
immunization with P. gingivalis does not afford protection but,
rather, appears to potentiate the abortifacient and embryotoxic
effects of LPS challenge during pregnancy.
In these studies we have used P. gingivalis A7436, a clinical
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isolate from a refractory periodontitis patient extensively char-
acterized by V. R. Dowell, Anaerobic Microbiology Labora-
tory, Centers for Disease Control, Atlanta, Ga. P. gingivalis
grown on blood agar plates in an anaerobic chamber for 1 to 2
days until the culture reached an A660 of 1.2, which corre-
sponded to approximately 109 CFU/ml. P. gingivalis LPS was
extracted by a modification of the Westphal-Jann method as
described by Kasper et al. (3) and resolved by CsCl density
gradient centrifugation and Limulus amoebocyte lysate identi-
fication of fractions. E. coli LPS (serotype 0127:B48) was
purchased from Sigma (St. Louis, Mo.) and used as the enteric
LPS.
Golden hamsters (Charles River Laboratories, Wilmington,
Mass.) were maintained in a breeding colony, mated, chal-
lenged, and sacrificed by following the teratology-toxicology
pregnancy model described initially by Ornay (5). For intrave-
nous challenge, the female was anesthetized to allow injection
with various dosages of LPS or buffer (final volume, 0.1 ml)
into the lingual vein. Pregnant dams were weighed and moni-
tored daily for signs of malaise, fever, and abortion. On day 15,
pregnant dams were euthanized by CO2 asphyxiation and
weighed, and the uterus was dissected for a thorough exami-
nation of implantation sites, individual embryos, and lethality
determination. The mean fetal weight was determined for each
pregnant dam, pooling results for six or more dams to form a
group mean ± standard error at each LPS dosage tested. Fetal
death was expressed as a percentage of total implantation sites
per litter which had either a resorption site or a nonvital fetus,
again pooling results for multiple dams at each LPS concen-
tration. Malformations were determined by gross inspection
(examining for skeletal anomalies), expressed as percentage of
total implantation sites per litter. A significant association
between pregnancy outcome (for example, fetal weight) and
LPS concentration was determined by repeated-measures
analysis of variance (ANOVA) at P < 0.05. When significant
dose-response effects were observed by analysis of variance,
pairwise comparisons between LPS responses at different
dosages were tested for significance by using the nonpaired t
test.
In certain experiments, animals were preimmunized with
either whole formalinized P. gingivalis bacteria (strain A7436)
or isolated LPS. Prior to mating, animals were immunized
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intravenously with daily doses of formalinized P. gingivalis
starting at 3x 107 cells increasing incrementally 20% daily for
5 days. Similarly, other animals were administered incremental
intravenous doses of P. gingivalis LPS for 5 days starting at
10,ug/100 g of body weight (gbw) and increasing 20% daily.
Ten days later the animals were boosted by repeating the last
dose and mated 2 weeks later. A postmating challenge of P.
gingivalis LPS at various doses was administered at day 8 of
pregnancy.
By comparing single doses of eitherE. coli or P. gingivalis
LPS in the pregnant hamster, we have observed both qualita-
tive and quantitative differences in pregnancy outcome re-
sponses. The effects of E. coli and P. gingivalis LPS on fetal
weight are shown in Fig. 1. The dashed horizontal line
indicates the mean fetal weight of control (non-LPS-treated)
dams. This value of 1.55 ± 0.024 g (mean ± standard error)
was obtained by pooling results for 18 mothers and 255 fetuses.
There were no spontaneous abortions, no resorptions, no
visible congenital anomalies, and an average of 14.2 fetuses per
dam in control animals. The experimental data for mean fetal
weight at each LPS dosage are shown, with standard errors
shown by error bars. E. coli LPS (Fig. 1A) at dosages of 0.03
and 0.3,ug of LPS per 100 gbw induced statistically significant
increases in fetal weight (P < 0.01, nonpaired t test). However,
as the LPS dosage increased there were statistically significant
decreases in mean fetal weight with dosage of 10,ug/100 gbw,
resulting in an 18.1% decrease (P < 0.01). The decrease in
fetal weight in response to E. coli LPS occurred over a
relatively narrow dose-response range, because as the LPS
dose increases, the relative number of lethal fetal resorptions
also increases (Fig. 2A). The total number of implantation sites
per female cannot change, since this event occurs prior to LPS
challenge. Thus, as theE. coli LPS dose increases, the number
and the size of the viable fetuses decrease. The effects of P.
gingivalis LPS on fetal weight are shown in Fig. 1B. The
dose-response curve shows a biphasic effect on fetal weight
over the dose range of 0.003 to 10 jig of LPS per 100 gbw,
which was almost identical to that obtained from E. coli LPS.
There are more data for intermediate P. gingivalis LPS con-
centrations emphasizing the ability of doses of 30 to 300 ng to
induce significant increases in fetal weight. Larger challenges
(3 to 10 jig) with P. gingivalis LPS doses cause a significant
decrease in mean fetal weight. However, in contrast to E. coli
LPS, doses of P. gingivalis LPS of 30 ,ug and above do not
influence fetal weight. This dose-response curve extends over 5
logs with an apparent window of embryotoxic activity which
influences fetal weight over a more narrow range of approxi-
mately 2.5 logs. The data showing the effect of LPS on fetal
resorptions (death) are shown in Fig. 2. There is little similarity
between E. coli and P. gingivalis LPS dose responses. At 10 ,ug
of E. coli LPS per 100 gbw, 66.4% of all fetuses are nonvital
and are resorbed (Fig. 2A) and the remaining viable fetuses
are dramatically smaller (Fig. 1). At 30 jig of E. coli LPS, there
are no viable fetuses, as 100% of the implantation sites have
resorbed. One-fourth of these animals also had signs of vaginal
discharge. At doses of 100 ,ug, all of the animals showed
vaginal discharge and 100% resorption upon sacrifice. In this
dose range of 30 to 100 jig/100 gbw, piloerection and lethargy
were observed as signs of fever and malaise; however, no
effects were seen on maternal weight at any of the dosages
tested. The maximum effect of P. gingivalis LPS on fetal
mortality (Fig. 2B) was observed at a dose of 300 ng of P.
gingivalis LPS, at which 21.7% of the fetuses were resorbed, a
statistically significant elevation as compared with results for
control animals. As levels of P. gingivalis LPS challenge
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FIG. 1. The effects on mean fetal weight of E. coli (panel A) and P.
gingivalis (panel B) LPS administered on day 8 of gestation in pregnant
hamsters. The dashed horizontal line represents the mean value for
control animals (no LPS).
as seen with E. coli LPS. In contrast, there was a return to
baseline in fetal weight (Fig. 1B) and percent resorptions (Fig.
2B), suggesting that single challenges of P. gingivalis LPS at
higher dosages failed to elicit an embryolethal effect.
This suggestion was also reflected in Fig. 3B, which indicates
that P. gingivalis LPS had minimal activity as an inducer of
congenital malformations. It was also significant that the
highest levels of P. gingivalis LPS caused slight fever in some
animals but failed to induce vaginal discharge, maternal shock,
or maternal death (data not shown). In contrast, E. coli LPS
(Fig. 3A) induced visible congenital malformations over the
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FIG. 2. The percent fetal death in response to E. coli (panel A) and
P. gingivalis (panel B) LPS. In this pregnant hamster model, embryo-
lethality is accompanied by resorption of the fetus.
all viable fetuses had visible skeletal malformations. Although
not characterized systematically, malformations included neu-
ral crest defects and cleft palate and limb anomalies.
Although a single challenge with P. gingivalis LPS failed to
demonstrate the same embryotoxicity as E. coli LPS, the effects
of repeated treatment with either whole P. gingivalis or P.
gingivalis LPS prior to mating on the pregnancy response
elicited by a P. gingivalis LPS challenge during pregnancy are
dramatic. Table 1 shows the effects of premating exposure with
either P. gingivalis LPS or whole cells on pregnancy outcome.
A single bolus of 1 ,ug of P. gingivalis LPS during pregnancy did
not result in a significant effect on fetal weight as compared to
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FIG. 3. The percent of congenital malformed fetuses in response to
E. coli (panel A) and P. gingivalis (panel B) LPS.
gbw during pregnancy resulted in a decrease in mean fetal
weight from 1.55 g (control dams) to 1.4 ± 0.08 g. This is
equivalent to a 9.7% reduction in weight. In contrast, animals
that were primed with LPS before mating, and challenged with
the same 3-,ug P. gingivalis LPS dose during pregnancy, had a
more pronounced decrease in fetal weight (P = 0.02). Priming
with P. gingivalis whole cells prior to mating also induced a
greater decrease in fetal weight following 1-,ug or 3-,ug preg-
nancy challenges. For example, 3-,ug challenges in nonprimed
animals resulted in a mean weight of 0.78 ± 0.08, or a 49.7%
reduction in the weight of surviving fetuses, at P < 0.001
relative to controls. Immunizations with whole cells resulted in






TABLE 1. Effects of intravenous treatment with either P. gingivalis
whole cells or isolated LPS on adverse pregnancy
outcomes induced by LPS
Premating treatment
and pregnancy Fetal wt (g) % Fetal death % Congenital
challenge (mean ± SE) (resorptions) malformations
(mg of LPS)
None
1 1.55 ± 0.13 11.3 0
3 1.40 ± 0.08 2.6 1.0
LPS (3) 1.14 ± 0.08a 31.3 8.3
Whole cell
1 1.26 ± 0.05 26.7 0
3 0.78 ± 0.08b 83.3 0
a P = 0.044 compared with 3 p.g pregnancy challenge and no premating
challenge.
b p = 0.0003.
animals when challenged with 3 ,ug of LPS per 100 gbw during
pregnancy.
LPS exposure before conception also potentiated the em-
bryolethal effects of P. gingivalis LPS, as shown in Table 1. In
unexposed animals, few resorptions occurred with P. gingivalis
LPS, reaching an apparent peak value of 21.7% at 0.3 ,ug/100
gbw. In contrast, animals that were primed with either P.
gingivalis LPS or whole cells were much more susceptible to
resorptions, closely mimicking the potent embryolethal re-
sponse observed for E. coli LPS. However, priming did not
appear to induce a large increase in the teratogenic response,
as reflected in the percent congenital malformations. Thus,
multiple preexposure with either whole P. gingivalis cells or
purified P. gingivalis LPS results in a marked potentiation of
the effects on decreasing fetal weight and increasing fetal
mortality.
This report demonstrates that the LPS from oral bacteria
can cause adverse pregnancy outcomes. We have shown that
increasing doses of LPS from both E. coli and P. gingivalis
produce biphasic effects on fetal weight with significant de-
creases in fetal weight at higher doses. Single doses of E. coli
LPS >10 ,ug/100 gbw were potent inducers of pathological
mechanisms leading to fetal morbidity and mortality. The fact
that single doses of P. gingivalis LPS failed to produce compa-
rable responses appears to be a result of primary versus
secondary challenge. Immunizing dams prior to mating with
the P. gingivalis LPS increased the pathogenicity of the day 8
pregnancy challenge to levels comparable with those for E.
coli. These findings pose new questions regarding the mecha-
nisms of potential adverse effects of chronic oral infections
with gram-negative organisms during pregnancy.
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